IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 174 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 877 | 0.0% | 0.00% | – |
| Q2 2023 | $6 | +20.0% | 877 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 877 | +49.7% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 586 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | 0.0% | 586 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | -25.0% | 586 | +27.9% | 0.00% | – |
| Q1 2022 | $8,000 | -11.1% | 458 | 0.0% | 0.00% | – |
| Q4 2021 | $9,000 | -30.8% | 458 | -13.7% | 0.00% | – |
| Q3 2021 | $13,000 | +62.5% | 531 | +82.5% | 0.00% | – |
| Q2 2021 | $8,000 | -11.1% | 291 | 0.0% | 0.00% | – |
| Q1 2021 | $9,000 | -30.8% | 291 | +5.4% | 0.00% | – |
| Q4 2020 | $13,000 | -51.9% | 276 | -66.3% | 0.00% | – |
| Q3 2020 | $27,000 | +28.6% | 819 | +15.0% | 0.00% | – |
| Q2 2020 | $21,000 | 0.0% | 712 | 0.0% | 0.00% | – |
| Q1 2020 | $21,000 | +5.0% | 712 | 0.0% | 0.00% | – |
| Q4 2019 | $20,000 | +42.9% | 712 | -9.3% | 0.00% | – |
| Q3 2019 | $14,000 | -26.3% | 785 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | +171.4% | 785 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | +75.0% | 785 | +95.8% | 0.00% | – |
| Q4 2018 | $4,000 | -20.0% | 401 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 401 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | -28.6% | 401 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | – | 401 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |